Article
Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis.
Frontiers in endocrinology - 1 Jan 2023
Janicki Lukasz, Patel Agastya, Jendrzejewski Jarosław, Hellmann Andrzej
Abstract excerpt
Background: Evidence suggests that patients with Hashimoto thyroiditis (HT) are at significantly higher risk of developing papillary thyroid cancer (PTC). However, the course of PTC in patients with both diseases concomitantly has been found to be more indolent than conventional PTC. Additionally, it has been well proven that BRAF mutation results in an aggressive course of PTC. The aims of this meta-analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
